Compounds > dichlororibofuranosylbenzimidazole
Page last updated: 2024-08-17

dichlororibofuranosylbenzimidazole and 4,5,6,7-tetrabromo-2-azabenzimidazole

dichlororibofuranosylbenzimidazole has been researched along with 4,5,6,7-tetrabromo-2-azabenzimidazole in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Bain, J; Battistutta, R; de Moliner, E; Elliott, M; Fabbro, D; Furet, P; Meggio, F; Pagano, MA; Pinna, LA; Ruzzene, M; Sarno, S; Schoepfer, J; Zanotti, G1
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Hirasawa, A; Kinoshita, T; Kitaura, K; Nakanishi, I; Nakaniwa, T; Sekiguchi, Y; Tada, T; Tsujimoto, G1
Bednarski, P; Götz, C; Hemmerling, HJ; Hundsdörfer, C; Jose, J; Le Borgne, M; Totzke, F1
Kimura, R; Matsuki, N1
Barata, JT; Brandalise, SR; Jotta, PY; Ribeiro, D; Silva, A; Silveira, AB; Yunes, JA1
Chen, H; Chen, SR; Hu, YM; Pan, HL1
Adade, CM; Atella, GC; Coelho, FS; Dutra, FL; Lopes, AH; Silva Neto, MAC; Vieira, DP1

Other Studies

8 other study(ies) available for dichlororibofuranosylbenzimidazole and 4,5,6,7-tetrabromo-2-azabenzimidazole

ArticleYear
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
    The Biochemical journal, 2003, Sep-15, Volume: 374, Issue:Pt 3

    Topics: Acetates; Animals; Casein Kinase II; Cell Line; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Jurkat Cells; Molecular Structure; Plant Proteins; Protein Serine-Threonine Kinases; Protein Structure, Quaternary; Quinazolines; Rats; Zea mays

2003
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
    Bioorganic & medicinal chemistry letters, 2009, Jun-01, Volume: 19, Issue:11

    Topics: Adenosine Triphosphate; Binding Sites; Casein Kinase II; Catalytic Domain; Crystallography, X-Ray; Ellagic Acid; Enzyme Inhibitors; Humans; Protein Structure, Tertiary

2009
Indeno[1,2-b]indole derivatives as a novel class of potent human protein kinase CK2 inhibitors.
    Bioorganic & medicinal chemistry, 2012, Apr-01, Volume: 20, Issue:7

    Topics: Casein Kinase II; Cell Membrane Permeability; Humans; Indoles; Kinetics; Protein Kinase Inhibitors; Stereoisomerism

2012
Protein kinase CK2 modulates synaptic plasticity by modification of synaptic NMDA receptors in the hippocampus.
    The Journal of physiology, 2008, Jul-01, Volume: 586, Issue:13

    Topics: Animals; Casein Kinase II; Cells, Cultured; Dichlororibofuranosylbenzimidazole; Enzyme Inhibitors; Hippocampus; Membrane Potentials; Neuronal Plasticity; Neurons; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Synapses; Triazoles

2008
Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors.
    Haematologica, 2010, Volume: 95, Issue:4

    Topics: Amyloid Precursor Protein Secretases; Blotting, Western; Casein Kinase II; Cell Proliferation; Cell Size; Child; Dichlororibofuranosylbenzimidazole; Drug Therapy, Combination; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Humans; Mutation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; PTEN Phosphohydrolase; Receptor, Notch1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Triazoles

2010
Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 349, Issue:2

    Topics: Animals; Calcineurin Inhibitors; Casein Kinase II; Dichlororibofuranosylbenzimidazole; Excitatory Postsynaptic Potentials; Hyperalgesia; Male; Miniature Postsynaptic Potentials; N-Methylaspartate; Physical Stimulation; Posterior Horn Cells; Rats, Sprague-Dawley; Spinal Cord; Tacrolimus; Touch; Triazoles

2014
Lysophosphatidylcholine triggers cell differentiation in the protozoan parasite Herpetomonas samuelpessoai through the CK2 pathway.
    Acta parasitologica, 2020, Volume: 65, Issue:1

    Topics: Animals; Casein Kinase II; Cell Differentiation; Dichlororibofuranosylbenzimidazole; Enzyme Inhibitors; Hemiptera; Lysophosphatidylcholines; Metabolic Networks and Pathways; Phospholipases A2; Triazoles; Trypanosomatina

2020